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Abstract
The last decade has witnessed significant advances in imaging of the middle and 
inner ear and the auditory pathways. High resolution computerized tomography 
(CT) scanners and new magnetic resonance (MR) sequences have been imple-
mented in clinical practice as valuable supportive tools for the Audiologist in the 
identification of the site of lesion and for the surgical planning by the Otologist. 
The purpose of this chapter is to review the current advanced methods of neuro-
radiological evaluation of patients with sensorineural hearing loss (SNHL), either 
congenital or acquired, especially focusing on the assessment of candidates to 
cochlear implantation (CI), with plenty of explicative images.
Keywords: sensorineural hearing loss, congenital inner ear malformations, acquired 
inner ear disorders, flat panel CT, high-resolution MR-sequences
1. Introduction
The imaging assessment of the inner ear and the auditory pathway requires 
high-resolution techniques because their anatomical structures are small and 
complex. In the last 10 years, computed tomography (CT) and magnetic resonance 
(MR) has reached much higher spatial resolution for bony and neural structures.
Multi-section CT (MSCT) is the technique of choice for the study of the tem-
poral bone, thanks to its high spatial resolution. However flat panel CT (FPCT) 
constitutes the newest alternative technique, since it guarantees some additional 
advantage compared with MSCT in terms of ultra-high isotropic spatial resolution 
(~150 × 150 × 150 μm3) and reduction of the effective dose of up to 40% [1–3].
On the other hand, 3 Tesla MR scanners, thanks to the high-resolution sequences 
such as tridimensional (3D) T2 weighted sequence (3D-T2w, spatial resolution: 0.4 
× 0.4 × 0.6 mm3, field of view: 140 × 140 mm, time of scan: 5′ 32″) and 3D Fluid 
Attenuated Inversion Recovery (FLAIR), have provided new insight to detect 
changes in the inner ear [4, 5]. MR is technique of choice to study the peripheral and 
central auditory pathways.
The purposes of this chapter is to review the state of the art of pre-operative 
neuroradiological assessments of patients with sensorineural hearing loss 
(SNHL) especially focusing on candidates to a cochlear implant (CI). Advanced 
imaging of the morphology and the integrity of anatomical structures will 
be presented in order to show the current capabilities of correct site of lesion 
identification.
Advances in Rehabilitation of Hearing Loss
2
2. Inner ear and cochlear-vestibular nerve
2.1 Congenital disorders
Inner ear can be affected by malformative and acquired anomalies, which can 
cause profound to severe hearing impairment. FPCT scan is more accurate than 
conventional MSCT in the morphologic evaluation of inner ear; FPCT allows 
an excellent examination of the 32-mm spiral canal of the snail-shaped cochlea, 
that winds 2 and ½ turns around the modiolus. These turns are separated by 
interscalar septa, where defects of it and of the modiolus can describe different 
types of incomplete partition of the cochlea. Sennaroğlu and Bajin summarized 
the findings of abnormalities involving each inner ear structure, as described in 
Table 1 [6].
The most common cochlea anomalies are incomplete partition type I (IP-I) 
and incomplete partition type II (IP-II). In the IP-I, the cochlea results in a cystic 
appearance, due to the lack of the entire modiolus and the cribriform area, associ-
ated with a large cystic vestibule. In the IP-II (classic Mondini deformity), the 
cochlea forms a cystic apex, due to the coalescence of the middle and the apical 
turns, accompanied by a dilated vestibule and enlarged vestibular aqueduct 
(Figure 1). A rare disorder associated with congenital mixed hearing loss is incom-
plete partition type III, an X-Linked inner ear anomaly, caused by the absence of the 
bony modiolus and of the septum between the base of the cochlea and the internal 
auditory canal, with no associated anomalies in the vestibular structures of the 
inner ear (Figure 2) [6, 7]. This anomaly is associated with fixed stapes footplate, 
which represents a surgical risk of perilymph gusher during stapedectomy, and it 
represents even a risk of misdirected insertion of the cochlear electrode through the 
internal acoustic canal, inside the cerebellopontine angle against the brain stem, 
during cochlear implantation (Figure 3).
Cochlear malformations can be accompanied by anomalies of the vestibule or of 
the semicircular canals, resulting in aplasia, hypoplasia or dilatation [8].
Another cause of SNHL is the presence of enlarged vestibular aqueduct 
described as larger than 1.5 mm at the midpoint in the axial plane between the 
common crus and the external aperture, associated with a normal cochlea, vestibule 
and semicircular canals [8]. The Pöschl projection improves the accuracy in the 
measurement of the aqueduct. It is defined as 45° from either the sagittal or coronal 
Type of IEM Radiological findings
Complete labyrinthine aplasia Absent labyrinth
Rudimentary otocyst Incomplete millimetric otic capsule remnant
Cochlear aplasia Absent cochlea
Common cavity Round or ovoid cystic structure for cochlea and vestibule
Cochlear hypoplasia Cochlear size small
Incomplete partition—I Cystic cochlea
Incomplete partition—II Cystic cochlea apex
Incomplete partition—III Modiolus absent, interscalar septa present
Enlarged vestibular aqueduct Normal cochlea with enlarged vestibular aqueduct
Cochlear acqueduct abnormalities Narrow or absent cochlear acqueduct
Table 1. 
Sennaroğlu and Bajin’s description of the findings of abnormalities involving inner ear structures.
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planes or perpendicular to the long axis of the pyramid, or parallel to the superior 
semicircular canal (Figure 4) [9].
Enlarged vestibular aqueduct, accompanied by enlarged endolymphatic sac, 
can be associated with other cochlear and vestibular anomalies, which can affect 
therapeutic strategies: scalar asymmetry with enlargement of anterior chamber 
composed of the scala vestibuli and the scala media, or modiolar deficiency that 
shows a flattened and attenuated modiolus, well evaluated in 3D-T2w (Figure 5).
It is important to identify the atresia or the hypoplasia of the cochlear canal, 
by measuring the length and the width of the bony canal of the cochlear nerve, 
respectively obtained by drawing a perpendicular line from the base of the modio-
lus to the inner margin of the fundus of the internal auditory canal (IAC) and by 
drawing a line along the inner bony margins (Figure 6). The measurements can 
detect a hypoplastic bony canal, which may be indicative of a embryologic malfor-
mation of the cochlear-vestibular nerve (CVN), in patients with congenital SNHL 
[10–12].
The presence of aplasia or hypoplasia of the CVN must be ruled out since may 
affect the choice of surgical technique and CI device, as well as the performance 
Figure 1. 
FPCT on axial plane showing IP-II deformity (classic Mondini deformity): the cochlea forms a cystic apex, due 
to the fusion of the middle and the apical turns (arrow, A), accompanied by a dilated vestibule (long arrow, B) 
and enlarged vestibular aqueduct (short arrow, B).
Figure 2. 
FPCT on axial plane showing IP-III deformity (arrow), caused by the absence of the bony modiolus and of the 
septum between the base of the cochlea and the internal auditory canal.
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outcome following CI; in patients whose cochlear nerves are missing, an auditory 
brain stem implant should be considered [13].
The presence of a normal cochlea does not exclude the agenesis of the cochlear 
nerve because of the different embryogenesis of the otic labyrinth and its neural 
Figure 5. 
3D-T2w on 3 Tesla MR on axial plane showing enlarged endolymphatic sacs (arrows), associated with enlarged 
vestibular aqueducts.
Figure 3. 
FPCT on axial plane showing a complicated insertion of cochlear implant in IP-III deformity. The CI electrode 
enters the internal acoustic canal, reaching the cerebellopontine angle.
Figure 4. 
FPCT on Pöschl projection (A), which is reconstructed approximately 45° from either the sagittal and coronal 
planes, parallel to the loop of the superior semicircular canal, and axial plane (B) between the common crus 
and the external opening, showing an enlarged vestibular aqueduct (arrows).
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elements. Nevertheless the cochlear nerve malformations are often associated 
with labyrinthine abnormalities [10]. As mentioned above, the hypoplasia of the 
cochlear canal seen on CT scan is a sensitive indicator of CVN malformation: in 
that case the CT evaluation should be always followed by MR examination since the 
3D-T2w is the most valuable tool to assess nerves anomalies.
The relationship between the facial and the CVN within the IAC may vary 
among individuals (Figures 7 and 8).
2.2 Acquired disorders
Among acquired lesions in SNHL, the presence and the extension of a laby-
rinthine ossification represents another great challenge for the surgeon, owing to 
difficult insertion of the electrode array. It may occur like “end-stage” of different 
labyrinthine pathologies, categorized as infective or non-infective, including 
meningitis, otitis media, trauma, otosclerosis and labyrinthectomy. Fibrosis can 
precede ossification but extensive fibrosis without ossification rarely occurs. The 
Figure 6. 
FPCT on axial plane showing aplasia of cochlear canal (arrow, A) and normal cochlear canal (arrow, B). The 
measurement of the length and the width of the bony cochlear canal are made by drawing a perpendicular line 
from the base of the modiolus to the inner margin of the fundus of the internal acoustic meatus and by drawing 
a line along the inner margins of its bone edges (B).
Figure 7. 
3D-T2w on 3 Tesla MR on axial plane showing normal appearance of cochlear and inferior vestibular nerves 
(arrows, A), facial and superior vestibular nerves (arrow, B).
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stage of fibrosis begins ~2 weeks after the onset of infection, but CT images remains 
elusive. Instead, 3D-T2w demonstrates replacement of the normally fluid-filled 
spaces of the labyrinth, resulting in reduced T2w signal and shows the presence of 
labyrinthine enhancement after gadolinium. MR images have the advantage of not 
only diagnosing cochlear obstruction, but even better sensitivity for estimating the 
extent of fibrous obstruction, subtle at CT images, thus allowing earlier diagnosis 
(Figures 9 and 10) [14].
The end stage of the ossification results in the absence of T2w signal of the 
labyrinth; this stage is also well seen from CT images (Figure 11).
Reduced T2w signal is reported in vestibular schwannoma, up to 10–20% of the 
causes of SNHL, but it always results in intralabyrinthine contrast enhancement 
(Figure 12).
The management of far advanced otosclerosis may represent another impor-
tant objective in the era of CI [15]. In the original otosclerosis, the aberrant bone 
deposition around the stapes footplate results in the impairment of the mechanical 
transmission of sound, leading to conductive hearing loss. In advanced otosclerosis, 
Figure 9. 
FPCT on axial (A) and para-coronal (B) planes showing minimal ossification of the basal turn of the cochlea.
Figure 8. 
3D-T2w on 3 Tesla MR showing normal appearance of cochlear nerve on axial (arrow, A) and sagittal plane 
(arrow, C) and aplasia of cochlear nerve on axial plane (arrow, B) and on sagittal plane (arrow, D).
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bone deposits can extend into the bony labyrinth of the inner ear, surrounding 
the cochlea and resulting in a mixed conductive and SNHL. Advanced otosclerosis 
with cochlear involvement may influence the insertion and the performance of a 
CI. Despite in these patients the CI has proven to be the most effective treatment 
modality, endoluminal otospongiotic obstruction may complicate the insertion of 
the array and alter the spread of the electrical stimulation. Pre-operative CT may 
clearly detect ossification of the cochlea (Figure 13) [16].
Until recently, MR imaging with and without contrast media has been used only 
to exclude cochlear causes of sudden SNHL (SSHL), such as a vestibular schwan-
noma, and rare causes of retrocochlear SSHL including demyelinating disease, 
brain stem infarctions and cerebellopontine tumors.
Nowadays, pre-contrast T1-weighted and 3D-FLAIR sequence may suggest the 
pathogenesis of SSHL.
Two specific patterns can be identified: the “vascular” pattern, characterized 
by the presence of methemoglobin in the inner ear that appears as hyperintense 
on both pre-contrast T1-weighted and 3D-FLAIR images (Figure 14), and the 
“inflammatory” pattern which shows high signal only on 3D-FLAIR sequence, due 
to the presence of proteins in the inner ear fluids (Figure 15). Both patterns can be 
associated with enhancement on post-contrast 3D-FLAIR which suggests the blood-
labyrinth breakdown [17].
Figure 10. 
3-Tesla MR shows loss of signal of the left cochlea and vestibule on axial T2w sequence (arrow, A), and 
enhancement after contrast-medium administration on axial T1w (arrow, B), suggesting intralabyrinthine 
fibrosis. At 1-year follow-up, MRI shows loss of signal of the left cochlea on T2w sequence (long arrow, C), 
without enhancement after contrast-medium administration, compatible with complete ossification; MR 
findings suggest that active fibrosis is still present within the left vestibule (short arrow, C and D).
Figure 11. 
FPCT on axial plane showing the “end stage” of the ossification of the cochlea (arrow, A) and semicircular 
lateral canal (arrow, B).
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MR sequences, in particular 3D-T2, are excellent to analyze inner ear fluids 
intensity, and to investigate the morphology of the inner ear structures, cranial 
nerve VIII, internal auditory canal and cerebellopontine angle [18, 19].
Post-contrast 3D-FLAIR sequences are able to identify pathological conditions 
characterized by blood-labyrinth barrier breakdown, including viral infection, 
immune-mediated inner ear disease, perilymphatic fistulas [20, 21].
Furthermore, the 4 h-delayed 3D-FLAIR sequences on 3 Tesla scanner after 
intravenous administration of gadolinium-based contrast agent offer enough spatial 
resolution to detect small endolymphatic structures, such as saccule and utricle; in 
this sequences the endolabyrinth appears to have a lower signal compared with the 
surrounding perilymph.
Figure 13. 
FPCT on axial plane shows a peri-cochlear hypodensity (arrow) compatible with advanced otosclerosis.
Figure 12. 
MR images 3D-T2 (A) showing reduced T2 signal of the right cochlea and vestibule (arrow); after intravenous 
contrast-medium administration T1w sequence (B) shows cochlear and vestibular enhancement (arrow), due 
to intralabyrinthine schwannoma.
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Figure 14. 
Vascular pattern of SSHL. Pre-contrast T1w (A) and 3D-FLAIR (B) sequences show a high signal in the 
right cochlea (arrow), without enhancement on postcontrast T1w (arrow, C). The inner ear enhancement on 
3D-FLAIR sequence is consistent with blood-labyrinth barrier breakdown of the inner ear (arrow, D).
Figure 15. 
Inflammatory pattern of SSHL. The pre-contrast T1w (arrow, A) shows no signal abnormalities. The pre-
contrast 3D-FLAIR (arrow, B) shows a high signal in the basal turn of the right cochlea. A postcontrast T1-w 
sequence (arrow, C) does not show enhancement, whereas a postcontrast 3D-FLAIR sequence (arrow, D) shows 
the basal turn of the cochlea markedly enhanced on the right side.
Figure 16. 
Axial 3D-FLAIR sequence after 4-h from intravenous contrast-medium administration (A) shows right 
vestibular (long arrow) and cochlear (short arrow) hydrops, compared with the normal left inner ear 
(arrowheads). On oblique sagittal plane (B), the 4-h delayed postcontrast 3D-FLAIR sequence confirms the 
right vestibular endolymphatic hydrops, in particular of the saccule (arrow), while in the left ear (C), the 
inferior third of the vestibule is normally filled by perilymph (arrow).
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In patients with Meniere’s disease, the pathological finding is represented 
by endolymphatic hydrops, characterized by a distension of the endolymphatic 
space of the inner ear into areas that are normally filled with perilymphatic liquid 
(Figure 16). CI is an effective means of treatment of patients with end-stage 
Meniere’s disease affected by severe-to-profound SNHL [22–24].
3. Auditory central nervous system
The auditory central system includes: the cochlear nucleus and the superior 
olivary complex in the pons, the inferior colliculus in the midbrain, the medial 
geniculate nucleus of the thalamus and the auditory cortex (i.e. Heschl’s gyrus) in 
the temporal lobe.
Nowadays, MR imaging is the modality of choice to investigate the auditory cen-
tral pathway, because of its better sensitivity and specificity compared with others 
neuro-imaging modalities (CT and, in the newborn, ultrasound scanning).
The auditory pathway myelination begins during the fetal life and increases up 
to the first year of age, reflecting the improvement of the auditory system func-
tion. The changes in myelin can be seen using MR imaging by the 37th fetal week 
in the brainstem and later in the structure higher in the auditory pathway, as early 
as 10 weeks of age in the medial geniculate nucleus and by 24 weeks in subcortical 
white matter (Figure 17) [25, 26].
The 3T MR scanner, thanks to its high contrast and spatial resolution, guarantees 
great sensitivity in the detection of white matter injury, playing an important role in 
the early diagnosis of some pathologies related with congenital SNHL [27].
In addition to conventional MR sequences, some advanced techniques such as 
diffusion tensor imaging (DTI) and functional MR imaging (fMRI), may be helpful 
to provide new insight into structural and functional white matter changes in early 
stage of congenital SNHL [28]. On the other hand, the investigation of the first step 
of the central auditory pathway, i.e. cochlear nucleus, is challenging and currently 
limited in clinical practice. The most promising MR sequences are T2-weighted 
Figure 17. 
Sagittal T1w sequence in a healthy 42-weeks newborn shows the normal myelination pattern (as hyper-intense 
signal) in the cortical rim of the Heschl’s girus (arrow).
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gradient-echo (T2GE) imaging and susceptibility weighted imaging (SWI), which 
ensure a good contrast resolution between hypointensity of the nuclei, due to 
paramagnetic deposition, and hyperintensity of the surrounding myelinated tissue.
Both environmental and genetic pathologies may lead to congenital SNHL, with 
possible involvement of any component of acoustic pathway [29, 30].
Frequently, the anatomical structure primarily involved in inherited hearing loss 
are the inner ear and the CNV (discussed in the previous chapter), while the audi-
tory central pathway is spared by any lesion at the conventional MR investigation.
Conversely, the central system is commonly involved in acquired SNHL disor-
ders. Cytomegalovirus (CMV) is the most common congenital non-genetic cause of 
SNHL [31]. About 10% of CMV infection results in several brain abnormalities. At 
present, an official guideline on the preferred neuroimaging modalities to identify 
brain abnormalities in patients with CMV infection is lacking; the current practice 
varies according to center-based protocols [32].
MR imaging is more sensitive than ultrasound scanning in the detection of 
mild and severe brain abnormalities, such as: microcephaly, cerebellar hypopla-
sia, cortical anomalies, calcification, white matter changes, polar temporal lesion, 
Figure 18. 
MR findings in four patients with congenital cytomegalovirus infection: cerebellar hypoplasia (A); perisylvian 
polymicrogyria (B) that involves the right Heschl’s gyrus (arrow); intraventricular septation (C) in the 
occipital horn of the lateral ventricles (arrows, C); hyperintensity of the anterior temporal white matter  
(D, arrows).
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sub-ependimal cyst, ventriculomegaly and intraventricular septa (Figure 18). 
The combination of these malformations depends on gestation age at time of 
infection [33, 34].
Unfortunately, up to date no specific MR finding is significantly associated with 
the hearing impairment and outcome of treatment [35]. Moreover, all the above 
mentioned findings are common to several conditions associated with SNHL and 
should be considered in the differential diagnosis.
Considering others congenital infections, toxoplasmosis and rubella are com-
monly described as sharing similar pictures with CMV. In countries where the 
rubella immunization programs are in place, a congenital infection is currently rare; 
nevertheless, this diagnostic hypothesis should be considered in presence of brain 
calcifications, white matter lesions, intraventricular septations, subependymal 
germinolytic cysts and ventriculomegaly. Noteworthy, newborns affected by CMV 
showing with brain abnormalities are usually asymptomatic from a neurological 
standpoint, but may develop progressive SNHL only later on in life [36, 37].
Other rare causes of acquired hearing loss, occurring whenever the auditory 
central pathway is involved in the injury, are focal brain lesions following perinatal 
ischemic or hemorrhagic event may (Figure 19), hypoxic-ischemic encephalopathy 
(HIE) (Figure 20) [38, 39]. Therapeutic hypothermia, which is the only approved 
treatment for HIE, because it reduces the extension of brain lesions, has been 
unfortunately associated with SNHL. The correlation between imaging and func-
tional outcome is still unknown; up to 10% of the treated babies develop hearing 
impairment.
Figure 19. 
Images showing the evolution of perinatal ischemic injury involving the right temporal lobe and the right basal 
ganglia. Axial T2w (A), coronal T2w (B) and DWI (C) images of 2 days newborn during the acute phase of 
the ischemic injury. Axial T2w (D), coronal T2w (E) and axial T1w (F) images showing the massive damage 
after 42 days; the involvement of the primary auditory cortex (arrows) caused SNHL.
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MR studies with DWI sequence are widely used as an early outcome measure 
after hypothermia.
MR spectroscopy, measuring cerebral metabolites changes, has recently been 
investigated as a possible tool in predicting neurodevelopmental outcomes in new-
born with HIE [40]. In the near future, advanced MR technique might be also used 
to investigate possible correlation between hypothermia and deafness [41].
In conclusion, the latest neuroimaging techniques play a relevant role in the 
diagnosis of congenital and acquired disorders underlying SNHL. While advanced 
MR sequences allow to clarify possible differential diagnoses and to achieve a cor-
rect identification of the site of lesion from the inner ear to the auditory cortex, the 
combination of FPCT and MR undoubtedly support the clinicians in the counseling 
and management of patient’s candidate to CI.
Figure 20. 
Images showing the evolution of HIE in a term newborn. In the acute phase, axial T1w section (A) shows 
hyperintensity of the right Heschl’s gyrus (arrow) and mild hyperintensity of the basal ganglia (arrowheads), 
while the coronal T2w section (B) demonstrates a widely hyperintense white matter (arrow). After 1 week: the 
axial T1w (C) and coronal T2w (D) sections show chronic changes, with more prominent signal changes in the 
white matter and basal ganglia and loss of brain matter.
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